Prelude Capital Management’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-3,413
| Closed | -$14K | – | 1336 |
|
|
2020
Q2 | $14K | Buy |
+3,413
| New | +$14K | ﹤0.01% | 1007 |
|
|
2020
Q1 | – | Sell |
-1,840
| Closed | -$11K | – | 926 |
|
|
2019
Q4 | $11K | Sell |
1,840
-320
| -15% | -$1.91K | ﹤0.01% | 1226 |
|
|
2019
Q3 | $11K | Sell |
2,160
-260
| -11% | -$1.32K | ﹤0.01% | 1006 |
|
|
2019
Q2 | $15K | Sell |
2,420
-160
| -6% | -$992 | ﹤0.01% | 958 |
|
|
2019
Q1 | $23K | Buy |
2,580
+8
| +0.3% | +$71 | ﹤0.01% | 929 |
|
|
2018
Q4 | $21K | Sell |
2,572
-1,500
| -37% | -$12.2K | ﹤0.01% | 915 |
|
|
2018
Q3 | $56K | Sell |
4,072
-17,343
| -81% | -$239K | ﹤0.01% | 792 |
|
|
2018
Q2 | $170K | Buy |
21,415
+18,684
| +684% | +$148K | 0.01% | 625 |
|
|
2018
Q1 | $20K | Buy |
2,731
+1,378
| +102% | +$10.1K | ﹤0.01% | 1111 |
|
|
2017
Q4 | $9K | Sell |
1,353
-11
| -0.8% | -$73 | ﹤0.01% | 1073 |
|
|
2017
Q3 | $10K | Sell |
1,364
-1,087
| -44% | -$7.97K | ﹤0.01% | 1298 |
|
|
2017
Q2 | $11K | Buy |
+2,451
| New | +$11K | ﹤0.01% | 1255 |
|